US Patent 7741519 Bis-aryl sulfonamides
Patent 7741519 was granted and assigned to ChemoCentryx on June, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+338 characters)
Article
Patent abstract
Compounds are provided that act as potent antagonists of chemokine receptors. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of chemokine receptor-mediated diseases, and as controls in assays for the identification of chemokine antagonists.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Andrew Pennell0
Brett Permack0
John J. Wright0
Solomon Ungashe0
Thomas Schall0
Zheng Wei0
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07741519 Bis-aryl sulfonamides US Patent 7741519 Bis-aryl sulfonamides
Infobox
Patent Number
077415190
Patent Number
77415190
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077415190
Date of Patent
June 22, 2010
0Patent Application Number
120248600
Date Filed
February 1, 2008
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07741519 Bis-aryl sulfonamides
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07741519
Date of patent
June 22, 2010
Patent application number
12024860
Date Filed
February 1, 2008
Patent primary examiner
Find more entities like US Patent 7741519 Bis-aryl sulfonamides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
